Top compounds associated with response to R3HDML


Feature Type Standardized
Nominal ANOVA
mRNA CIL55 CTRPv2 pan-cancer AAC -0.0041 0.9
mRNA 681640 GDSC1000 pan-cancer AAC 0.0026 0.9
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0024 0.9
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.0024 0.9
mRNA indisulam CTRPv2 pan-cancer AAC 0.0022 0.9
mRNA tivozanib GDSC1000 pan-cancer AAC 0.0023 0.9
mRNA ML006 CTRPv2 pan-cancer AAC 0.0024 0.9
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC 0.0034 0.9
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0021 0.9
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.0075 1
Download CSV